The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Azaphilones from an Acid Mine Extremophile Strain of a Pleurostomophora sp.EBI
Memorial Sloan-Kettering Cancer Center
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.EBI
Memorial Sloan-Kettering Cancer Center
Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associatedµ opioid receptor (MOR-1) splice variants.EBI
Memorial Sloan-Kettering Cancer Center
Generation of novel radiolabeled opiates through site-selective iodination.EBI
Memorial Sloan-Kettering Cancer Center
Diversity-oriented synthesis: exploring the intersections between chemistry and biology.EBI
Memorial Sloan-Kettering Cancer Center
Discovery and development of heat shock protein 90 inhibitors.EBI
Memorial Sloan-Kettering Cancer Center
Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase.EBI
Memorial Sloan-Kettering Cancer Center
Role of metalation in the topoisomerase IIa inhibition and antiproliferation activity of a series ofa-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.EBI
Memorial Sloan-Kettering Cancer Center
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.EBI
Memorial Sloan-Kettering Cancer Center
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.EBI
Memorial Sloan-Kettering Cancer Center
Synthesis of a red-shifted fluorescence polarization probe for Hsp90.EBI
Memorial Sloan-Kettering Cancer Center
Synthesis of Hsp90 dimerization modulators.EBI
Memorial Sloan-Kettering Cancer Center
Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.EBI
Memorial Sloan-Kettering Cancer Center
Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.EBI
Memorial Sloan-Kettering Cancer Center
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90.EBI
Memorial Sloan-Kettering Cancer Center
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.EBI
Memorial Sloan-Kettering Cancer Center
Development of CBAP-BPyne, a probe for γ-secretase and presenilinase.EBI
Memorial Sloan-Kettering Cancer Center
Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70.EBI
Memorial Sloan-Kettering Cancer Center
Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.EBI
Memorial Sloan-Kettering Cancer Center
Development of clickable active site-directed photoaffinity probes for γ-secretase.EBI
Memorial Sloan-Kettering Cancer Center
Stereo-controlled synthesis of novel photoreactive gamma-secretase inhibitors.EBI
Memorial Sloan-Kettering Cancer Center
PROTEASE INHIBITORS AND METHODS OF MAKING SAMEBDB
Variational AI
Tertiary amines for use in the treatment of cardiac disordersBDB
Universitetet I Oslo
Inhibitors of the renal outer medullary potassium channelBDB
Merck Sharp & Dohme
Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.BDB
Mcgill University
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design.BDB
Johnson & Johnson Pharmaceutical